Revance therapeutics inc.

Major-Pharmaceuticals

RVNC


7555 Gateway Boulevard
Newark , CA 94560

Executive/
Director

Price

  • Last Close
  • $ 3.02
    $ -3.55 -54.03 %
    Dec 9, 2024
  • 52-Week High/Low
  • $18.16 - $2.34
  • YTD
  • -65.6%

  • Trading Volume
  • 439,790
  • Market Cap Full
  • $ 265.2M
  • Shares Outstanding
  • 87.8M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 22.4% -48.9% 0.5% -13.9% -21.7% -5% -1.4% 19.3% 74.5% -44%
Q2 54.3% -22.1% 26.9% -8% -16.2% 4% 6.1% -29% -21.4% -4.7%
Q3 -6.9% 19.2% 4.4% -9.3% 3.6% 8% -6% 95.4% -54.7% -
Q4 14.8% 27.7% 26.3% -17.8% 24.1% 12.7% -41.4% -31.6% -21.5% -
J F M A M J J A S O N D
2024 -42.8% 42% -31.1% -8.3% - - - - - - - -
2023 87.9% 0.1% -7.2% -1.2% -4% -17.2% -6.6% -25.4% -34.9% -31.2% -14.2% 29.8%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%102%-39%73%-44%-20%75%-42%13%-52%-66%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.65 0.71 0.94 -0.97 -0.85 -1.15 -1.08 -0.94 -0.74
Q2 0.71 0.88 0.90 -0.94 -0.86 -1.12 -1.07 -0.88 -0.80
Q3 0.81 0.64 1.01 -0.91 -0.96 -1.34 -1.1 -1.17 -1.63
Q4 0.83 0.95 1.14 -1.12 -1 -1.25 -0.92 -1.91 -
A 3 3.2 4 -3.9 -3.7 -4.9 -4.2 -4.9 -3.17

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 44 56.9 71.4 71.5 82.8
Jun 36.8 44 57.1 71.5 72.8 84
Sep 36.9 44.1 65.9 71.8 73.1 88
Dec 37 45.1 66.5 71.8 82.3 87.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.9 2.3 0.8 - -
Fixed Asset Turnover 2.1 2 0.7 - 0.2
Total Asset Turnover 0.2 0.2 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -24.4 -45.8 -30.3 32.8 -
Equity multiplier 4.9 0.6 0.1 0.1 0.1